1. Home
  2. DCTH vs TRAK Comparison

DCTH vs TRAK Comparison

Compare DCTH & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • TRAK
  • Stock Information
  • Founded
  • DCTH 1988
  • TRAK 1990
  • Country
  • DCTH United States
  • TRAK United States
  • Employees
  • DCTH N/A
  • TRAK N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • TRAK EDP Services
  • Sector
  • DCTH Health Care
  • TRAK Technology
  • Exchange
  • DCTH Nasdaq
  • TRAK Nasdaq
  • Market Cap
  • DCTH 387.2M
  • TRAK 418.7M
  • IPO Year
  • DCTH N/A
  • TRAK 1998
  • Fundamental
  • Price
  • DCTH $10.91
  • TRAK $22.69
  • Analyst Decision
  • DCTH Strong Buy
  • TRAK Strong Buy
  • Analyst Count
  • DCTH 4
  • TRAK 1
  • Target Price
  • DCTH $21.50
  • TRAK $24.00
  • AVG Volume (30 Days)
  • DCTH 363.4K
  • TRAK 60.8K
  • Earning Date
  • DCTH 11-08-2024
  • TRAK 02-12-2025
  • Dividend Yield
  • DCTH N/A
  • TRAK 0.27%
  • EPS Growth
  • DCTH N/A
  • TRAK 7.98
  • EPS
  • DCTH N/A
  • TRAK 0.30
  • Revenue
  • DCTH $22,644,000.00
  • TRAK $20,834,350.00
  • Revenue This Year
  • DCTH $1,605.13
  • TRAK $15.09
  • Revenue Next Year
  • DCTH $111.67
  • TRAK $15.00
  • P/E Ratio
  • DCTH N/A
  • TRAK $80.09
  • Revenue Growth
  • DCTH 945.91
  • TRAK 7.18
  • 52 Week Low
  • DCTH $3.43
  • TRAK $9.66
  • 52 Week High
  • DCTH $13.30
  • TRAK $25.01
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 57.95
  • TRAK 49.39
  • Support Level
  • DCTH $11.67
  • TRAK $23.36
  • Resistance Level
  • DCTH $13.30
  • TRAK $25.01
  • Average True Range (ATR)
  • DCTH 0.73
  • TRAK 0.98
  • MACD
  • DCTH 0.01
  • TRAK -0.08
  • Stochastic Oscillator
  • DCTH 34.60
  • TRAK 15.56

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.

Share on Social Networks: